Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  European Heart Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/OXFORDJOURNALS.EURHEARTJ.A060043PMID 1533587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Metoprolol on Diet‐Induced Atherosclerosis in Rabbits

  1988cited by this paper
• The role of sympathetic activity in atherogenesis: effects of beta-blockade.

  1988cited by this paper
• Influence of long-term metoprolol treatment on early and late exercise test performance after acute myocardial infarction.

  1988cited by this paper
• Prognosis after withdrawal of chronic postinfarction metoprolol treatment: a 2-7 year follow-up.

  1988cited by this paper
• The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assessed in the Göteborg metoprolol trial.

  1986cited by this paper
• Evaluation of antiarrhythmic effect of metoprolol treatment after acute myocardial infarction: relationship between treatment responses and survival during a 3-year follow-up.

  1986cited by this paper
• The effects of metoprolol given early in acute myocardial infarction on ventricular arrhythmias.

  1986cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity.

  1985cited by this paper
• Very early intervention with metoprolol in suspected acute myocardial infarction.

  1985cited by this paper
• Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold.

  1983cited by this paper
• A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias.

  1983cited by this paper
• Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.

  1981cited by this paper
• The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

  1978cited by this paper

• (Beta-blockers in the secondary prevention of myocardial infarction with respect to recent results of ABYSS and REDUCE-AMI trials)

  2025cites this paper
• Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.

  2025cites this paper
• The role of β‐adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β‐adrenergic receptor agonists and antagonists protect the heart?

  2024cites this paper
• Sex specific considerations in cardiovascular drug therapy.

  2024cites this paper
• Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis

  2023cites this paper
• Autonomic heart rate modulation in patients with coronavirus disease 2019 in mechanical ventilation

  2023cites this paper
• Sex-Based Difference in the Effect of Metoprolol on Heart Rate and Bradycardia in a Population-Based Setting

  2022cites this paper
• Cardiovascular Medications

  2021cites this paper
• Women are started on a lower daily dose of metoprolol than men irrespective of dose recommendations: A potential source of confounding by contraindication in pharmacoepidemiology

  2021cites this paper
• Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials.

  2020cites this paper
• An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.

  2020cites this paper
• Microvolt T-Wave Alternans: Pathophysiology and Clinical Aspects

  2019cites this paper
• Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia

  2018cites this paper
• Healthy Lifestyle and Cardiac Vagal Modulation Over 10 Years: Whitehall II Cohort Study

  2017cites this paper
• Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension

  2016cites this paper
• Heart Rate Recovery Index Was Deteriorated In Diastolic Dysfunction

  2016cites this paper
• Are Changes in Heart Rate Variability in Middle‐Aged and Older People Normative or Caused by Pathological Conditions? Findings From a Large Population‐Based Longitudinal Cohort Study

  2016cites this paper
• Nationale Versorgungsleitlinie (NVL) Chronische KHK

  2016cites this paper
• Quantitative T-wave alternans analysis for sudden cardiac death risk assessment and guiding therapy: answered and unanswered questions: For: Proceedings of ICE2015 Comandatuba, Brazil, Sudden Death Symposium.

  2016cites this paper
• Prevention of Sudden Cardiac Death Using β-Blockers

  2016cites this paper
• Model Formulation n

  2016cites this paper
• Nationale Versorgungsleitlinie (NVL) Chronische KHK

  2016cites this paper
• Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today?

  2015cites this paper
• Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.

  2015cites this paper
• En la era actual existe beneficio pronóstico del tratamiento con bloqueadores beta tras un síndrome coronario agudo con función sistólica conservada

  2015cites this paper
• Selective late INa inhibition by GS-458967 exerts parallel suppression of catecholamine-induced hemodynamically significant ventricular tachycardia and T-wave alternans in an intact porcine model.

  2015cites this paper
• Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.

  2015cites this paper
• Quantitative T-wave alternans analysis for guiding medical therapy: an underexploited opportunity.

  2015cites this paper
• Primary and Secondary Prevention of Ischemic Heart Disease in Women

  2015cites this paper
• Role of the Autonomic Nervous System in Ventricular Arrhythmias During Acute Myocardial Ischemia and Infarction

  2015cites this paper
• Pharmacotherapy Considerations in Cardiovascular Disease in Women: Therapeutic Implications for Cardiovascular Disease

  2014cites this paper
• Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.

  2014cites this paper
• Life is what happens to you while you´re busy making other plans

  2014cites this paper
• Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms.

  2014cites this paper
• Sex‐based differences in cardiac ischaemic injury and protection: therapeutic implications

  2014cites this paper
• Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications.

  2013cites this paper
• A Pharmacokinetic and Pharmacodynamic Comparison of Immediate-Release Metoprolol and Extended-Release Metoprolol CR/XL in Patients with Suspected Acute Myocardial Infarction: A Randomized, Open-Label Study

  2013cites this paper
• Pathophysiological relevance of the cardiac β2-adrenergic receptor and its potential as a therapeutic target to improve cardiac function.

  2013cites this paper
• The role of the autonomic nervous system in cardiac arrhythmias.

  2013cites this paper
• Clinical applications of T-wave alternans assessed during exercise stress testing and ambulatory ECG monitoring.

  2013cites this paper
• The lis study (Lyubertsy study on mortality rate in patients after acute myocardial infarction). Evaluation of drug therapy. Part 2. Influence of previous drug treatment on long-term life prognosis

  2012cites this paper
• Risk Stratification for Prevention of Sudden Cardiac Death

  2012cites this paper
• Under-Utilisation of b-Blockers After Acute Myocardial Infarction

  2012influential citation
• Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?

  2012cites this paper
• β-Blockers in the Management of Hypertension in Patients with Type 2 Diabetes Mellitus

  2012cites this paper
• Acute myocardial infarction in men and women - different impact of smoking in the two genders. : Analyses of a cohort study of 2281 patients admitted to hospital

  2012cites this paper
• "Gender-specific drug prescription in Germany" results from prescriptions analyses.

  2012cites this paper
• Chapter 46 – Sleep-Related Cardiac Disorders

  2012cites this paper
• Women and the management of acute coronary syndrome.

  2012cites this paper
• Management and Outcome in ST-Elevation Myocardial Infarction from a Gender Perspective

  2012cites this paper
• Gender differences in the treatment of ischemic heart disease.

  2011cites this paper
• and Clinical UtilityConsensus Guideline by International Society for Holter Microvolt T-Wave Alternans: Physiological Basis, Methods of Measurement,

  2011cites this paper
• Bundesärztekammer Kassenärztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften

  2011cites this paper
• Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.

  2011cites this paper
• Differences in Efficacy and Safety of Pharmaceutical Treatments between Men and Women: An Umbrella Review

  2010cites this paper
• [Sex differences and cardiovascular drugs].

  2010cites this paper
• Proceedings from the Scientific Symposium: Sex Differences in Cardiovascular Disease and Implications for Therapies

  2010cites this paper
• Drug Class Review: Beta Adrenergic Blockers

  2009cites this paper
• Enhanced Predictive Power of Quantitative TWA during Routine Exercise Testing in the Finnish Cardiovascular Study

  2009cites this paper
• Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.

  2009cites this paper
• Koronarsykdom hos kvinner og menn: Fellestrekk og ulikheter i forekomst, risikofaktorer og behandling

  2009cites this paper
• Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program

  2009cites this paper
• CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

  2008cites this paper
• Эффективность и безопасность Эгилока ретард при лечении артериальной гипертензии у пожилых людей

  2008cites this paper
• Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications.

  2008cites this paper
• Sudden cardiac death and the role of medical therapy.

  2008cites this paper
• Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.

  2008cites this paper
• General introduction and outline of the thesis

  2008cites this paper
• Primary prevention of sudden cardiac death: apart from the defibrillator, what is important in patients with myocardial infarction or heart failure?

  2007influential citation
• 08 Kurpesa.p65

  2007cites this paper
• Prewencja kardiologiczna

  2007cites this paper
• Sudden cardiac death: epidemiology, mechanisms, and therapy.

  2007cites this paper
• CHAPTER 35 – Atherothrombosis and Coronary Artery Disease

  2007cites this paper
• Lipophilicity of Beta‐Adrenocepter Antagonists: A New Classification Scheme for Clinical Use

  2007cites this paper
• Influence of Nebivolol and Metoprolol on Inflammatory Mediators in Human Coronary Endothelial or Smooth Muscle Cells. Effects on Neointima Formation After Balloon Denudation in Carotid Arteries of Rats Treated with Nebivolol

  2007cites this paper
• Hospital discharge against advice after myocardial infarction: deaths and readmissions.

  2007cites this paper
• Drug Class Review on Beta Adrenergic Blockers: Final Report

  2007cites this paper
• EGYETEMI DOKTORI (Ph.D.) ÉRTEKEZÉS ÚJABB KLINIKAI EREDMÉNYEK BÉTA-RECEPTOR BLOKKOLÓKKAL

  2006cites this paper
• The Anti-Ischemic Effect of Metoprolol in Patients with Chronic Angina Pectoris Is Gender-Specific

  2006cites this paper
• Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities.

  2006cites this paper
• Beta-Blockers in Heart Failure

  2006cites this paper
• Non-arrhythmic therapy of ventricular tachyarrhythmias and sudden cardiac death after acute myocardial infarction.

  2006cites this paper
• The Anglo‐Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm

  2006cites this paper
• Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept

  2005cites this paper
• Are β-Blockers Useful to Protect High-Risk Patients Scheduled for Open Cholecystectomy?

  2005cites this paper
• (-Blockade in the Primary Prevention of Coronary Heart Disease in Hypertensive Patients

  2005cites this paper
• Myocardial Infarction Effects of B-Blockade

  2005cites this paper
• Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.

  2005cites this paper
• Drug Class Review on Beta Adrenergic Blockers

  2005cites this paper
• Paracrine effect of human vascular endothelial cells on human vascular smooth muscle cell proliferation: Transmembrane co-culture method

  2005cites this paper
• Serum Upids and Cholesterol-Weeks After 10 Weeks of ETS Exposure ETS No ETS P Metoprolol Saline Metoprolol Saline ETS

  2005cites this paper
• Alpha-crystallin: an ATP-independent complete molecular chaperone toward sorbitol dehydrogenase

  2005cites this paper
• The impact of lipophilicity in drug research: a case report on beta-blockers.

  2005cites this paper
• β-Blocker Underuse in Secondary Prevention of Myocardial Infarction

  2004cites this paper
• Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

  2004cites this paper
• Comparison of mortality in mexican-american females and mexican american males following acute myocardial infarction

  2004cites this paper
• Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patients.

  2004cites this paper
• Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.

  2004cites this paper
• Evidence-based guidelines for cardiovascular disease prevention in women.

  2004cites this paper
• [The use of beta-blockers in patients with hypertension and chronic obstructive lung diseases].

  2004cites this paper